Articles from Imperative Care

Imperative Care, a medical technology company focused on advancing the treatment of thromboembolic disease, today announced new findings from a pre-specified sex-specific analysis of the SYMPHONY-PE IDE Trial, published simultaneously in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) and presented by Aymen Ahmed, MD, of Endeavor Health Cardiovascular Institute, at Transcatheter Cardiovascular Therapeutics (TCT) 2026. The analysis found that women and men with intermediate-risk pulmonary embolism (PE) experienced substantial clot burden reduction, improvements in right-heart function, and broadly comparable short-term clinical and safety outcomes following aspiration thrombectomy with the Symphony Thrombectomy System, despite women demonstrating greater evidence of cardiac stress at baseline with similar initial clot burden.

Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation neurovascular guidewire purpose-built to improve vascular access during stroke procedures.

Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the appointment of Jay Martin as Chief Commercial Officer (CCO). Jay will lead the company's commercial strategy with a focus on advancing alignment between commercial and product development, expanding strategic partnerships, and building the scalable infrastructure required to support Imperative Care's continued growth and commercialization efforts.

Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced that new data from studies evaluating the Zoom Stroke Solution were presented at the Society of NeuroInterventional Surgery (SNIS) 2023 20th Annual Meeting in San Diego, Calif.

Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom™ 88 Large Distal Platform (LDP) Support, a portfolio expansion of the company’s Zoom 88 Large Distal Platform.

Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced the appointment of Ariel Sutton to the newly-created position of General Manager of the company’s Stroke business.

Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by vascular diseases, today announced the formation of Kandu Health, a digital health startup company with the aim of changing the course of stroke recovery and post-acute care.